Oncology Grand Rounds Series: Part 2 — Hodgkin and Non-Hodgkin Lymphomas

Video proceedings from the second in a series of 6 integrated symposia held at the 2019 ONS Annual Congress. Featuring perspectives from Dr Christopher R Flowers, Ms Amy Goodrich, Dr Patrick B Johnston and Ms Robin Klebig: Introduction (00:00) Program overview: Dr Love Hodgkin Lymphoma (HL) (2:51) Case (Ms Klebig): A woman in her early 50s with HL who received up-front brentuximab vedotin with ABVD on a clinical trial and nivolumab after relapse (5:57) Case (Ms Goodrich): A man in his mid-50s with relapsed HL who received brentuximab vedotin as a bridge to allogenic transplant (26:12) Follicular Lymphoma (FL) (37:16) Case (Ms Klebig): A man in his late 50s with multiply relapsed FL who received lenalidomide/rituximab with response and clinical improvement (38:46) Case (Ms Goodrich): A man in his late 40s with relapsed FL who received copanlisib (1:07:01) Mantle Cell Lymphoma (MCL) (1:09:53) Case (Ms Goodrich): A man in his early 80s with relapsed MCL and multiple comorbidities who received acalabrutinib (1:19:36) Case (Ms Goodrich): A man in his early 60s who received multiple lines of therapy for relapsed MCL, including venetoclax/rituximab (1:27:21) Diffuse Large B-Cell Lymphoma (DLBCL) (1:34:06) Case (MS Klebig): A woman in her mid-30s with relapsed triple-hit DLBCL who underwent chimeric antigen receptor T-cell therapy (1:34:12) Case (Ms Klebig): A woman in her mid-30s with DLBCL who received CNS prophylaxis with high-dose methotrexate (1:37:16) Select publications